Pulmonx Corporation to Showcase Innovations at Key Medtech Event

Author: Dominic Sanders Updated: 02-13-2025 04:17 PM

Pulmonx Corporation Set to Shine at Major Medtech Gathering

Pulmonx Corporation, recognized as a global leader in minimally invasive treatments for severe lung diseases, is excited to announce its upcoming participation in the Citi 2025 Unplugged Medtech and Life Sciences Access Day. This significant event is scheduled to take place in New York, providing a great platform for Pulmonx to outline its cutting-edge advancements in respiratory health.

Overview of the Event and Pulmonx's Role

During the event, Pulmonx will engage in a fireside chat that is expected to shed light on the company's latest innovations and the future of treatments for chronic obstructive pulmonary disease (COPD). Scheduled for 8:00 AM PT / 11:00 AM ET, this discussion promises to be insightful for attendees, offering a closer look at the technologies that are transforming patient care.

Accessing the Presentation

For those unable to attend the event in person, Pulmonx will provide a live and archived webcast of the presentation. Interested individuals can easily access this via the Investors section of the Pulmonx website.

About Pulmonx Corporation

Pulmonx Corporation (Nasdaq: LUNG) stands at the forefront of healthcare innovation, specializing in minimally invasive solutions aimed at treating severe emphysema and the debilitating effects of COPD. Their flagship products include the Zephyr Endobronchial Valve and the Chartis Pulmonary Assessment System, which enhance patient outcomes significantly.

Innovative Products Driving Change

The Zephyr Valve, a pioneering treatment device, has garnered attention for its effectiveness and has received FDA pre-market approval as a breakthrough device. Currently available in over 25 countries, it is included in global treatment guidelines, establishing itself as a standard of care for patients struggling with emphysema. This has not only improved patients’ breathing but also their overall quality of life, allowing them to participate more fully in daily activities.

Future Directions for Pulmonx

Looking ahead, Pulmonx aims to continue expanding its product offerings and enhancing its technology to better serve patients with severe lung disorders. With a commitment to innovation and patient care, the company is poised to play a crucial role in the evolution of respiratory treatments.

Building Stronger Connections

Pulmonx encourages all stakeholders and interested parties to stay informed about its advancements and future initiatives. The company is dedicated to transparency and openness, inviting feedback and engagement from the community.

Frequently Asked Questions

What is the Citi 2025 Unplugged Medtech and Life Sciences Access Day?

This event is a key gathering for leaders in the medical technology and life sciences sectors, showcasing innovations and advancements in patient care.

What products does Pulmonx offer?

Pulmonx offers several innovative products, including the Zephyr Endobronchial Valve and the Chartis Pulmonary Assessment System, aimed at treating severe lung diseases.

How can I access the Pulmonx presentation at the event?

The presentation will be available via a live and archived webcast on the Pulmonx website.

Where is Pulmonx Corporation based?

Pulmonx Corporation is based in Redwood City, California, and operates globally to reach patients in need of advanced lung disease treatments.

Who can I contact for more information about Pulmonx?

For inquiries, you can contact Brian Johnston at the Gilmartin Group via email.

About The Author

Dominic Sanders here, a writer and financial specialist committed to helping my readers understand the world of finance. Having a strong financial background and a lot of experience, I concentrate on using my blog posts and articles to translate difficult financial subjects into understandable, doable advice. My goal in writing is to arm you with the information and skills need to make wise financial choices.

Writing for several financial blogs has let me interact with a wide range of readers, from novice investors seeking new perspectives to seasoned investors. My mission is to make money understandable and approachable so you may confidently take charge of your financial future. I appreciate you walking this road with me to success and financial literacy.

Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.